Related Experiment Video
Updated: May 29, 2026
08:58
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Fetal hyperglycemia alters lung structural development in neonatal rat
Anna Koskinen1, Heikki Lukkarinen, Niko Moritz
1The Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. anviar@utu.fi
Pediatric Pulmonology
|September 10, 2011
Summary
Maternal hyperglycemia in rats impacts fetal lung development, causing early structural changes and increased cell proliferation. These alterations suggest abnormal lung maturation in response to a high-sugar prenatal environment.
Area of Science:
- Developmental biology
- Endocrinology
- Pulmonology
Background:
- Maternal diabetes mellitus increases risks for fetal organ development abnormalities.
- The specific impact of maternal hyperglycemia on developing lungs remains unclear.
Purpose of the Study:
- To investigate the effects of maternal hyperglycemia on postnatal lung development in rats.
- To analyze structural and cellular changes in neonatal lungs following intrauterine hyperglycemia.
Main Methods:
- Hyperglycemia was induced in Sprague-Dawley rats using streptozotocin prior to pregnancy.
- Lung tissues were analyzed on postnatal days 0, 7, and 14 for weight, morphology, apoptosis (TUNEL), and proliferation (PCNA).
- Quantitative micro-CT was used to assess lung vasculature at day 14.
Main Results:
- Newborn rats from hyperglycemic dams showed decreased relative lung weight, thinner alveolar septa, and increased apoptosis and proliferation.
- Postnatal lung cell proliferation and the number of secondary crests were elevated in the hyperglycemia group at 1 and 2 weeks.
- Lung vasculature density and structure were not significantly affected by maternal hyperglycemia.
Conclusions:
- Maternal hyperglycemia is linked to structural developmental alterations in postnatal rat lungs.
- These early lung changes may indicate aberrant maturation in response to the hyperglycemic fetal environment.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...